Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We report here the analyses of complete mtDNA coding region sequences from more than 270 Alzheimer’s disease (AD) patients and normal controls to determine if inherited mtDNA mutations contribute to the etiology of AD. The AD patients and normal individuals were carefully screened and drawn from two populations of European descent in an effort to avoid spurious effects due to local population anomalies. Overall, there were no significant haplogroup associations in the combined AD and normal control sequence sets. Reduced median network analysis revealed that the AD mtDNA sequences contained a higher number of substitutions in tRNA genes, and that there was an elevated frequency of replacement substitutions in the complex I genes of the control sequences. Analysis of the replacement substitutions indicated that those arising in the AD mtDNAs were no more deleterious, on average, than those in the control mtDNAs. The only evidence for the synergistic action of mutations was the presence of both a rare non-conservative replacement substitution and a tRNA mutation in 2 AD mtDNAs, from a total of 145, whereas such a combination of mutations was not observed in the control sequences. Overall, the results reported here indicate that pathogenic inherited mtDNA mutations do not constitute a major etiological factor in sporadic AD. At most, a small proportion of AD patients carry a pathogenic mtDNA mutation and a small proportion of cognitively normal aged individuals carry a mtDNA mutation that reduces the risk of AD.
- Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?
Volume 119, Issue 3 , pp 241-254
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Mitochondrial Research Group, School of Neurology, Neurobiology, and Psychiatry, The University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
- 2. MitoKor Inc. (now MIGENIX Corp.), San Diego, CA, USA
- 3. Department of Neurosciences, University of California San Diego, San Diego, CA, USA
- 4. Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
- 5. Department of Neurology, Cornell University Medical College, New York, NY, USA
- 6. MRC/University of Newcastle upon Tyne Development Centre for Clinical Brain Ageing, Newcastle upon Tyne, United Kingdom
- 7. MIGENIX Corp., Suite 210, 12780 High Bluff Drive, San Diego, CA, 92130, USA
- 8. Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, TX, USA